Overview
- Quantinuum, which filed Friday, chose a traditional IPO route that requires fuller disclosures and SEC review.
- The company intends to list on the Nasdaq Global Select Market under the ticker QNT.
- J.P. Morgan and Morgan Stanley are set as joint lead bookrunners, with Jefferies and Evercore ISI also on the syndicate.
- The registration is not yet effective and the filing does not set a share count or price range.
- Financials show $30.9 million in 2025 revenue and a $192.6 million net loss, and reports suggest a roughly $1 billion raise at a valuation above $20 billion that the S-1 does not confirm.